WGS
GeneDx Holdings Corp. NASDAQ Listed Nov 4, 2020$56.42
-6.90%
vs $60.60
Mkt Cap $1.5B
52w Low $34.51
16.5% of range
52w High $167.52
50d MA $54.92
200d MA $99.77
P/E (TTM)
-77.3x
EV/EBITDA
216.3x
P/B
4.9x
Debt/Equity
0.5x
ROE
-6.8%
P/FCF
106.4x
RSI (14)
60.90
ATR (14)
$4.16
Beta
2.19
50d MA
$54.92
200d MA
$99.77
Avg Volume
1.5M
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
North Tower · Stamford, CT 06902 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | AMC | -0.06 | -0.28 | -366.7% | 67.93 | -45.6% | -49.2% | +0.6% | +16.7% | +0.7% | -2.8% | — |
| Feb 23, 2026 | AMC | 0.11 | 0.14 | +27.3% | 87.08 | -3.5% | -7.3% | -2.2% | +3.1% | -2.1% | -6.9% | — |
| Oct 28, 2025 | AMC | 0.28 | 0.49 | +75.0% | 137.47 | -0.7% | -4.2% | -0.2% | +4.1% | +1.0% | +0.9% | — |
| Jul 29, 2025 | AMC | 0.10 | 0.50 | +400.0% | 91.78 | +3.0% | +12.8% | -1.5% | -0.3% | +6.6% | -1.6% | — |
| Apr 30, 2025 | AMC | 0.11 | 0.28 | +154.5% | 66.85 | +6.7% | -6.8% | +7.9% | -1.6% | -4.4% | -9.4% | — |
| Feb 18, 2025 | AMC | 0.04 | 0.70 | +1650.0% | 112.76 | +0.2% | -1.3% | -8.7% | -5.7% | -0.9% | +0.9% | — |
| Oct 29, 2024 | AMC | -0.19 | 0.04 | +121.1% | 84.02 | +0.2% | -1.0% | -1.8% | -4.8% | -3.3% | -0.4% | — |
| Jul 30, 2024 | AMC | -0.26 | -0.11 | +57.7% | 30.13 | +16.2% | +8.6% | -1.4% | -6.8% | -6.3% | +2.2% | — |
| Apr 29, 2024 | AMC | -0.68 | -0.33 | +51.5% | 11.00 | +29.8% | +55.2% | +22.6% | -6.8% | +0.8% | -0.7% | — |
| Feb 20, 2024 | AMC | -0.60 | -0.59 | +1.7% | 5.24 | -5.7% | +32.6% | +18.1% | -4.0% | +3.2% | -0.9% | — |
| Oct 30, 2023 | AMC | -1.18 | -0.82 | +30.5% | 2.67 | -18.0% | -30.3% | +1.1% | -2.1% | -1.1% | -9.9% | — |
| Aug 8, 2023 | AMC | -1.47 | -1.65 | -12.2% | 6.65 | -2.1% | -12.6% | -8.4% | -0.9% | -0.9% | -1.7% | — |
| May 9, 2023 | AMC | -1.65 | -2.82 | -70.9% | 8.35 | -1.2% | -2.4% | -8.8% | -7.3% | +4.2% | -12.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $65.96 | $65.96 | +0.0% | +5.7% | -2.3% | +2.5% | -5.1% | +3.5% |
| Mar 30 | Guggenheim | Maintains | Buy → Buy | — | $57.09 | $57.09 | +0.0% | +4.4% | +7.7% | +2.0% | +1.0% | +0.6% |
| Feb 24 | Piper Sandler | Maintains | Overweight → Overweight | — | $87.08 | $84.02 | -3.5% | -7.3% | -2.2% | +3.1% | -2.1% | -6.9% |
| Feb 24 | BTIG | Maintains | Buy → Buy | — | $87.08 | $84.02 | -3.5% | -7.3% | -2.2% | +3.1% | -2.1% | -6.9% |
| Feb 9 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $84.29 | $89.54 | +6.2% | +8.2% | +3.9% | -3.5% | -0.8% | -0.6% |
| Dec 22 | Canaccord Genuity | Maintains | Buy → Buy | — | $140.44 | $142.00 | +1.1% | -0.2% | -3.4% | +0.5% | -1.7% | -3.3% |
| Dec 15 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $151.51 | $151.74 | +0.2% | -0.6% | -5.9% | -4.1% | +0.3% | +3.0% |
| Dec 12 | BTIG | Maintains | Buy → Buy | — | $155.37 | $157.15 | +1.1% | -2.5% | -0.6% | -5.9% | -4.1% | +0.3% |
| Nov 4 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $138.30 | $134.91 | -2.5% | +0.9% | -1.9% | +1.3% | +0.7% | +2.1% |
| Oct 29 | Guggenheim | Maintains | Buy → Buy | — | $137.47 | $136.54 | -0.7% | -4.2% | -0.2% | +4.1% | +1.0% | +0.9% |
| Oct 29 | BTIG | Maintains | Buy → Buy | — | $137.47 | $136.54 | -0.7% | -4.2% | -0.2% | +4.1% | +1.0% | +0.9% |
| Oct 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $137.47 | $136.54 | -0.7% | -4.2% | -0.2% | +4.1% | +1.0% | +0.9% |
| Oct 22 | BTIG | Maintains | Buy → Buy | — | $121.77 | $122.49 | +0.6% | -0.6% | +3.4% | +3.0% | +1.4% | +5.2% |
| Sep 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $123.20 | $126.83 | +2.9% | +2.2% | -1.5% | -1.5% | -0.5% | +5.4% |
| Aug 4 | Piper Sandler | Maintains | Overweight → Overweight | — | $101.60 | $103.03 | +1.4% | +6.6% | -1.6% | -0.8% | +0.1% | -0.8% |
| Jul 30 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $91.78 | $94.54 | +3.0% | +12.8% | -1.5% | -0.3% | +6.6% | -1.6% |
| Jun 30 | Guggenheim | Maintains | Buy → Buy | — | $91.10 | $93.17 | +2.3% | +1.3% | -2.2% | -0.6% | +2.0% | -6.4% |
| May 9 | Jefferies | Upgrade | Hold → Buy | — | $56.36 | $59.00 | +4.7% | +4.9% | -0.2% | +3.3% | -2.4% | +7.0% |
| May 1 | TD Securities | Maintains | Buy → Buy | — | $66.85 | $71.36 | +6.7% | -6.8% | +7.9% | -1.6% | -4.4% | -9.4% |
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $66.85 | $71.36 | +6.7% | -6.8% | +7.9% | -1.6% | -4.4% | -9.4% |
| Feb 19 | Goldman Sachs | Maintains | Neutral → Neutral | — | $112.76 | $112.94 | +0.2% | -1.3% | -8.7% | -5.7% | -0.9% | +0.9% |
| Jan 7 | TD Cowen | Maintains | Buy → Buy | — | $89.61 | $94.18 | +5.1% | +8.3% | -0.5% | -7.4% | -4.9% | -15.3% |
| Oct 30 | Craig-Hallum | Maintains | Buy → Buy | — | $84.02 | $84.20 | +0.2% | -1.0% | -1.8% | -4.8% | -3.3% | -0.4% |
| Oct 30 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $84.02 | $84.20 | +0.2% | -1.0% | -1.8% | -4.8% | -3.3% | -0.4% |
| Oct 30 | Goldman Sachs | Maintains | Neutral → Neutral | — | $84.02 | $84.20 | +0.2% | -1.0% | -1.8% | -4.8% | -3.3% | -0.4% |
| Oct 24 | Craig-Hallum | Maintains | Buy → Buy | — | $56.08 | $57.18 | +2.0% | +5.4% | -0.5% | -4.7% | +49.9% | -1.0% |
| Oct 16 | Goldman Sachs | Maintains | Neutral → Neutral | — | $59.99 | $60.50 | +0.9% | +1.3% | -7.9% | +7.2% | -3.1% | -0.7% |
| Jul 31 | TD Cowen | Maintains | Buy → Buy | — | $30.13 | $35.00 | +16.2% | +8.6% | -1.4% | -6.8% | -6.3% | +2.2% |
| Jul 31 | Goldman Sachs | Maintains | Neutral → Neutral | — | $30.13 | $35.00 | +16.2% | +8.6% | -1.4% | -6.8% | -6.3% | +2.2% |
| Jul 31 | BTIG | Maintains | Buy → Buy | — | $30.13 | $35.00 | +16.2% | +8.6% | -1.4% | -6.8% | -6.3% | +2.2% |
| Jul 31 | Craig-Hallum | Maintains | Buy → Buy | — | $30.13 | $35.00 | +16.2% | +8.6% | -1.4% | -6.8% | -6.3% | +2.2% |
| Jul 17 | Goldman Sachs | Maintains | Neutral → Neutral | — | $32.06 | $31.31 | -2.3% | +3.9% | -2.0% | -2.4% | +2.2% | +2.3% |
| Jun 26 | BTIG | Maintains | Buy → Buy | — | $27.25 | $28.25 | +3.7% | -3.9% | +1.7% | -1.9% | +9.8% | -3.2% |
| Apr 30 | BTIG | Maintains | Buy → Buy | — | $11.00 | $14.28 | +29.8% | +55.2% | +22.6% | -6.8% | +0.8% | -0.7% |
| Apr 30 | TD Cowen | Maintains | Buy → Buy | — | $11.00 | $14.28 | +29.8% | +55.2% | +22.6% | -6.8% | +0.8% | -0.7% |
| Apr 22 | BTIG | Maintains | Buy → Buy | — | $9.64 | $9.86 | +2.3% | +7.8% | +15.5% | -1.5% | -5.5% | -0.8% |
| Apr 15 | Goldman Sachs | Maintains | Neutral → Neutral | — | $9.62 | $9.78 | +1.7% | +2.7% | -2.7% | -4.3% | +4.0% | +0.7% |
| Nov 1 | Goldman Sachs | Maintains | Neutral → Neutral | — | $1.86 | $1.83 | -1.6% | +1.1% | -2.1% | -1.1% | -9.9% | -4.3% |
| Aug 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $6.65 | $6.51 | -2.1% | -12.6% | -8.4% | -0.9% | -0.9% | -1.7% |
| Jul 24 | Goldman Sachs | Maintains | Neutral → Neutral | — | $7.89 | $7.84 | -0.6% | -1.4% | -4.5% | -1.2% | -1.5% | -1.2% |
| Jul 21 | Goldman Sachs | Maintains | Neutral → Neutral | — | $7.60 | $7.63 | +0.4% | +3.8% | -1.4% | -4.5% | -1.2% | -1.5% |
| May 15 | Goldman Sachs | Maintains | Neutral → Neutral | — | $6.89 | $6.83 | -0.9% | +4.2% | -12.1% | -1.9% | -2.3% | +7.3% |
| Dec 7 | Goldman Sachs | Downgrade | Buy → Neutral | — | $10.00 | $10.07 | +0.7% | -5.3% | +6.3% | -10.2% | +1.4% | +4.4% |
| Nov 15 | TD Cowen | Maintains | Outperform → Outperform | — | $29.57 | $30.36 | +2.7% | -1.8% | -15.4% | -6.8% | -10.3% | +1.3% |
| Aug 18 | BTIG | Maintains | Buy → Buy | — | $44.22 | $44.88 | +1.5% | -3.7% | -7.8% | -4.2% | -1.8% | +6.2% |
| Aug 16 | Jefferies | Downgrade | Buy → Hold | — | $79.20 | $58.08 | -26.7% | -33.3% | -16.3% | -3.7% | -7.8% | -4.2% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 2,429 | $61.50 | $149K | 104,372 | — | — |
| Jun 16, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 5,932 | $60.83 | $361K | 106,801 | — | — |
| Jun 16, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 2,140 | $59.75 | $128K | 112,733 | — | — |
| Jun 16, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 863 | $61.50 | $53K | 39,954 | — | — |
| Jun 16, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 2,106 | $60.83 | $128K | 40,817 | — | — |
| Jun 16, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 760 | $59.75 | $45K | 42,923 | — | — |
| Jun 9, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 3,639 | $53.77 | $196K | 96,123 | -1.75% | +4.59% |
| Jun 9, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 1,266 | $53.77 | $68K | 36,486 | -1.75% | +4.59% |
| Jun 5, 2026 | Casdin Capital, LLCDir | — | Buy | 50,000 | $52.86 | $2.6M | 3,707,164 | +8.75% | +2.34% |
| Jun 4, 2026 | Casdin Capital, LLCDir | — | Buy | 150,000 | $56.44 | $8.5M | 3,657,164 | +8.75% | +2.34% |
| Jun 1, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 369 | $51.74 | $19K | 35,290 | +6.13% | -3.57% |
| May 20, 2026 | Casdin Capital, LLCDir | — | Buy | 140,000 | $43.81 | $6.1M | 3,507,164 | +5.81% | +4.02% |
| May 19, 2026 | Casdin Capital, LLCDir | — | Buy | 185,000 | $42.60 | $7.9M | 3,367,164 | +5.81% | +4.02% |
| May 18, 2026 | Casdin Capital, LLCDir | — | Buy | 175,000 | $42.55 | $7.4M | 3,182,164 | +5.81% | +4.02% |
| May 11, 2026 | Meister Keith A. | — | Buy | 532 | $40.35 | $21K | 4,433,297 | -0.30% | +4.76% |
| May 11, 2026 | Meister Keith A. | — | Buy | 252,734 | $39.65 | $10.0M | 4,432,765 | -0.30% | +4.76% |
| May 11, 2026 | Meister Keith A. | — | Buy | 246,734 | $38.91 | $9.6M | 4,180,031 | -0.30% | +4.76% |
| May 8, 2026 | Meister Keith A. | — | Buy | 73,104 | $41.15 | $3.0M | 3,933,297 | -0.30% | +4.76% |
| May 8, 2026 | Meister Keith A. | — | Buy | 79,144 | $40.67 | $3.2M | 3,860,193 | -0.30% | +4.76% |
| May 8, 2026 | Meister Keith A. | — | Buy | 3,396 | $38.70 | $131K | 3,781,049 | -0.30% | +4.76% |
| May 8, 2026 | Meister Keith A. | — | Buy | 15,745 | $38.00 | $598K | 3,777,653 | -0.30% | +4.76% |
| May 7, 2026 | Meister Keith A. | — | Buy | 56,630 | $40.46 | $2.3M | 3,761,908 | -0.30% | +4.76% |
| May 7, 2026 | Meister Keith A. | — | Buy | 94,356 | $39.39 | $3.7M | 3,705,278 | -0.30% | +4.76% |
| May 7, 2026 | Meister Keith A. | — | Buy | 116,412 | $38.46 | $4.5M | 3,610,922 | -0.30% | +4.76% |
| May 7, 2026 | Meister Keith A. | — | Buy | 123,393 | $37.60 | $4.6M | 3,494,510 | -0.30% | +4.76% |
| May 7, 2026 | Meister Keith A. | — | Buy | 14,786 | $36.33 | $537K | 3,371,117 | -0.30% | +4.76% |
| May 7, 2026 | Meister Keith A. | — | Buy | 128,181 | $35.46 | $4.5M | 3,356,331 | -0.30% | +4.76% |
| Apr 29, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 392 | $65.19 | $26K | 34,942 | +3.90% | +0.67% |
| Apr 29, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 18 | $64.12 | $1K | 93,216 | +3.90% | +0.67% |
| Apr 29, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 2,154 | $65.20 | $140K | 93,234 | +3.90% | +0.67% |
8-K · 5.02
!!! Very High
GeneDx Holdings Corp. -- 8-K 5.02: Executive Change
GeneDx Holdings Corp. (WGS) lost director Mark Gardner, signaling potential governance changes that investors should monitor for impact on board composition and strategic oversight.
Jun 16
8-K · 1.01
! Medium
GeneDx Holdings Corp. -- 8-K 1.01: Financing / Debt Agreement
GeneDx Holdings (WGS) secured a $100 million loan agreement, providing capital to support operations and potentially fund growth initiatives or reduce existing debt obligations.
Mar 2
8-K
GeneDx Holdings Corp. -- 8-K Filing
GeneDx reported 2025 fourth-quarter and full-year financial results, showing the rare disease diagnostics company's performance through its genomic sequencing business.
Feb 23
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 1,012,182 | $132M | Added | Dec 2025 |
| 2 | Ark Investment Management Llc | 1,324,583 | $85M | Added | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 858,583 | $55M | New | Mar 2026 |
| 4 | William Blair Investment Management, Llc | 775,269 | $50M | Reduced | Mar 2026 |
| 5 | Citadel Advisors Llc | 647,401 | $42M | Added | Mar 2026 |
| 6 | Jennison Associates Llc | 302,149 | $39M | Reduced | Dec 2025 |
| 7 | Franklin Resources Inc | 607,221 | $39M | Reduced | Mar 2026 |
| 8 | Raymond James Financial Inc | 610,073 | $39M | Added | Mar 2026 |
| 9 | Invesco Ltd. | 540,229 | $35M | Reduced | Mar 2026 |
| 10 | Bank Of New York Mellon Corp | 315,508 | $20M | Added | Mar 2026 |
| 11 | Fmr Llc | 295,621 | $19M | Reduced | Mar 2026 |
| 12 | Bank Of America Corp /de/ | 234,606 | $15M | Added | Mar 2026 |
| 13 | Aberdeen Group Plc | 230,096 | $15M | New | Mar 2026 |
| 14 | Qube Research & Technologies Ltd | 184,514 | $12M | Added | Mar 2026 |
| 15 | Northern Trust Corp | 175,767 | $11M | Reduced | Mar 2026 |
| 16 | Vanguard Portfolio Management Llc | 173,386 | $11M | New | Mar 2026 |
| 17 | Principal Financial Group Inc | 81,963 | $11M | Added | Dec 2025 |
| 18 | Voya Investment Management Llc | 80,081 | $10M | Reduced | Dec 2025 |
| 19 | Renaissance Technologies Llc | 153,716 | $10M | Added | Mar 2026 |
| 20 | Capital Research Global Investors | 151,055 | $10M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.52B
Enterprise Value
$1.43B
P/E (TTM)
-77.29x
Forward P/E
71.19x
PEG Ratio
2.67x
P/B
4.92x
P/S
3.55x
P/FCF
106.38x
EV/EBITDA
216.25x
Shares Out
26.9M
Financials (TTM)
Revenue
$427.5M
Net Income
-$21.0M
EBITDA
$6.6M
Free Cash Flow
$14.3M
Op Cash Flow
$33.3M
EPS Basic
$-0.73
EPS Diluted
$-0.73
EPS Forward
$0.79
Gross Margin
69.7%
Op Margin
-2.8%
Net Margin
-4.9%
Balance Sheet
Total Assets
$570.2M
Total Liab.
$262.0M
Total Equity
$308.2M
Cash
$171.3M
LT Debt
$87.0M
Book Value/Sh
$11.46
Debt/Equity
0.49x
Current Ratio
2.46
Quick Ratio
2.34
Returns & Growth
ROE
-6.8%
ROA
-4.0%
ROIC
-2.5%
Rev Growth YoY
+40.0%
EPS Growth YoY
+62.4%
Price Returns
2W
+33.8%
1M
-17.3%
3M
-34.8%
6M
-68.9%
12M
-27.0%
Technicals
52W High
$167.52
52W Low
$34.51
50d MA
$54.92
200d MA
$99.77
RSI (14)
60.90
ATR (14)
$4.16
Beta
2.19
Avg Volume
1.5M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$141.00
High
$170.00
Low
$100.00
Median
$150.00
Data updated apr 27, 2026 9:15am
· Source: financialmodelingprep.com